New blood test achieves 98% accuracy in diagnosing ALS

A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that effects neurons in the brain and spinal cord.

Sobi’s Aspaveli obtains indication extension approval in Europe

Aspaveli, known as Empaveli in the US, is approved there for the treatment of adults with PNH. Credit: swiftsciencewriting from Pixabay. Sobi has received approval

May 9, 2024

J&J opens SXSW as health sponsor

Johnson & Johnson is once again the sponsor of the health and medtech track at the SXSW Festival, and it’s featuring disease simulations in psoriatic

March 9, 2024

Stem Cell Injections in Mexico Led to Drug-Resistant Infections

Three patients developed difficult-to-treat Mycobacterium abscessus infections after receiving embryonic stem cell injections in Mexico in 2022, researchers reported. Two men — one from Colorado

May 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.